Quick Answer
MYRIAD GENETICS INC reported Operating Income of -$387.20 million for fiscal year 2025.
MYRIAD GENETICS INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$387.20M | -213.5% |
| 2024 | -$123.50M | +52.0% |
| 2023 | -$257.40M | -83.1% |
| 2022 | -$140.60M | +26.2% |
| 2021 | -$190.50M | +34.2% |
| 2020 | -$289.70M | -25.0% |
| 2020 | -$231.70M | -3148.7% |
| 2019 | $7.60M | -93.8% |
| 2018 | $121.90M | +177.0% |
| 2017 | $44.00M | -71.3% |
| 2016 | $153.40M | +14.8% |
| 2015 | $133.60M | -51.3% |
| 2014 | $274.40M | +20.4% |
| 2013 | $228.00M | +26.4% |
| 2012 | $180.32M | +14.3% |
| 2011 | $157.78M | +16.8% |
| 2010 | $135.07M | +6.8% |
| 2009 | $126.46M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$23.30M | -16.5% | +92.9% |
| June 30, 2025 | -$329.20M | -801.9% | -1035.2% |
| March 31, 2025 | -$29.00M | -3.9% | -45.0% |
| September 30, 2024 | -$20.00M | +66.7% | +45.2% |
| June 30, 2024 | -$36.50M | +67.9% | -30.8% |
| March 31, 2024 | -$27.90M | +46.6% | +53.6% |
| September 30, 2023 | -$60.10M | -33.6% | +47.1% |
| June 30, 2023 | -$113.70M | -538.8% | -117.8% |
- MYRIAD GENETICS INC showed a decrease of -213.5% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, MYRIAD GENETICS INC’s operating income has declined by 406.2% (from $126.46 million to -$387.20 million).
- The most recent figure is from MYRIAD GENETICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: